[Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders].
The article reviews current publications on the epidemiology, psychopathology, diagnostic criteria and comorbidity of most frequently encountered in the practice anxiety disorders: generalized anxiety disorder and panic disorder. Special attention is paid to the pharmacotherapy of anxiety disorders in the aspect of efficacy of main classes of drugs, including buspirone. The results of clinical trials of buspirone are presented.
A T
AT
Dzampaev
I A
IA
Suvorova
I V
IV
Damulin
D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D002065:Buspirone / Q000009:adverse effects / Q000627:therapeutic use*; D015897:Comorbidity; D006801:Humans; D016584:Panic Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D010698:Phobic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology
D014151:Anti-Anxiety Agents; D002065:Buspirone